Literature DB >> 14687666

Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression.

Andrew T Bender1, Cari L Ostenson, Daniela Giordano, Joseph A Beavo.   

Abstract

The cytokines macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) promote differentiation of monocytes into macrophages with distinct phenotypes and unique functional abilities. In this report, we characterize how monocytes and macrophages differentiated from monocytes with M-CSF and GM-CSF regulate their cGMP levels by controlling which phosphodiesterases (PDEs) and guanylyl cyclases (GCs) are expressed. We find that PDE1B and PDE2A are expressed at low levels in monocytes, but are the major cGMP PDEs expressed in macrophages. M-CSF differentiation triggers increased expression of PDE1B and PDE2A, while GM-CSF causes a large increase only in PDE1B. Based on PDE expression, we identified THP-1 and U937 cell lines as possible models for studying the roles of PDE1B and PDE2A in macrophage function. We additionally characterized changes in expression of GCs upon differentiation. We found that GM-CSF differentiation triggers a small decrease in soluble guanylyl cyclase (sGC) and a large increase in GC-A, while M-CSF significantly decreases sGC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687666     DOI: 10.1016/j.cellsig.2003.08.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  24 in total

Review 1.  Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.

Authors:  Isaac Levy; Anelia Horvath; Monalisa Azevedo; Rodrigo Bertollo de Alexandre; Constantine A Stratakis
Journal:  Curr Opin Pharmacol       Date:  2011-10-31       Impact factor: 5.547

Review 2.  PDE1 isozymes, key regulators of pathological vascular remodeling.

Authors:  Stefan Chan; Chen Yan
Journal:  Curr Opin Pharmacol       Date:  2011-09-29       Impact factor: 5.547

Review 3.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 4.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

5.  PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

6.  Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages.

Authors:  Bardia Askari; Jenny E Kanter; Ashley M Sherrid; Deidre L Golej; Andrew T Bender; Joey Liu; Willa A Hsueh; Joseph A Beavo; Rosalind A Coleman; Karin E Bornfeldt
Journal:  Diabetes       Date:  2007-01-26       Impact factor: 9.461

7.  Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.

Authors:  Otgonchimeg Rentsendorj; Franco R D'Alessio; David B Pearse
Journal:  J Leukoc Biol       Date:  2014-07-25       Impact factor: 4.962

8.  The DNA-binding factor Ctcf critically controls gene expression in macrophages.

Authors:  Tatjana Nikolic; Dowty Movita; Margaretha E H Lambers; Claudia Ribeiro de Almeida; Paula Biesta; Kim Kreefft; Marjolein J W de Bruijn; Ingrid Bergen; Niels Galjart; Andre Boonstra; Rudi Hendriks
Journal:  Cell Mol Immunol       Date:  2013-09-09       Impact factor: 11.530

9.  Knockdown of lung phosphodiesterase 2A attenuates alveolar inflammation and protein leak in a two-hit mouse model of acute lung injury.

Authors:  Otgonchimeg Rentsendorj; Mahendra Damarla; Neil R Aggarwal; Ji-Young Choi; Laura Johnston; Franco R D'Alessio; Michael T Crow; David B Pearse
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

10.  Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages.

Authors:  Angie L Hertz; Andrew T Bender; Kimberly C Smith; Mark Gilchrist; Paul S Amieux; Alan Aderem; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.